Navigation Links
DrugRisk Center Announces Court Postponement of NuvaRing Lawsuits
Date:12/5/2012

Dallas, TX (PRWEB) December 05, 2012

The DrugRisk Resource Center, a patient awareness group, is alerting women who suffered side effects after using the contraceptive NuvaRing that a judge recently postponed the start of important bellweather trials.

U.S. District Judge Rodney Sippel, who will preside over NuvaRing lawsuits filed by patients around the country, recently issued an order moving trial dates from May 6 to July 8, 2013.*

The change comes as the 2012 Statistical Analysis from the Judicial Panel on MultiDistrict Litigation reports as many as 1,028 NuvaRing lawsuits have been moved to Judge Sippel’s federal court in Missouri.** The formal case is known as In re: NuvaRing Products Liability Litigation, No. 08-md-1964, JPML, Eastern District Missouri.

Anyone who suffered blood clots, stroke, DVT or pulmonary embolism after using NuvaRing is urged to contact the DrugRisk Resource Center or speak with a lawyer about their legal rights as soon as possible and find out if a NuvaRing lawsuit is possible. The later trial dates will give those who have yet to learn their options after an injury more time to do so.

Experts have related vaginal rings like NuvaRing to higher blood clot risks than with traditional birth control pills.

The British Medical Journal published a Danish study on May 10, 2012 linking vaginal rings like NuvaRing to as much as a 90% increased risk of blood clots over oral contraceptives. On June 14, 2012, the New England Journal of Medicine also published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots.

So far, the FDA has received more than 1,000 reports of blood clot injury or death in patients using NuvaRing, according to an article in CBS News San Diego on September 21, 2012.

The DrugRisk Resource Center urges anyone affected by blood clots, stroke, DVT or pulmonary embolism after using NuvaRing to learn their treatment options and legal rights.

Due to the specialized nature of federal MDL drug injury cases, DrugRisk only recommends lawyers and law firms who have already handled NuvaRing lawsuits.

For more information on the research, side effects and litigation news related to NuvaRing and other drugs, or to speak with a lawyer, visit http://www.DrugRisk.com.

*Order # 1423, Novenber 20, 2012, Case: 4:08-md-01964-RWS
**http://www.jpml.uscourts.gov/sites/jpml/files/JPML_Statistical_Analysis_of_Multidistrict_Litigation-2012.pdf

Read the full story at http://www.prweb.com/releases/nuvaring-lawsuits/litigation-lawsuit/prweb10198897.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. UCLA Brain Injury Research Center gets NCAA funding for research on sports concussions
2. Weill Cornell Medical College establishes Center for Healthcare Informatics and Policy
3. American College of Cardiology cites new USF Simulation Center for Training Excellence
4. Kudos for 3 NJIT Enterprise Development Center high-tech companies
5. AFAR announces the 2012 Hartford Centers of Excellence in Geriatric Medicine awards
6. Loyola Cancer Center receives Outstanding Achievement Award
7. Hutchinson Center president elected to American Academy of Art and Sciences
8. Many Call Center Workers Plagued by Voice Woes
9. Specific protein triggers changes in neurons in brain reward center linked to cocaine addiction
10. IU Simon Cancer Center joins WellPoint in developing health care solutions
11. Moffitt Cancer Center researchers: Quality of life as important as quantity of life
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... Fla. (PRWEB) , ... October 12, 2017 , ... IsoComforter, ... therapy products, announced today the introduction of an innovative new design of the shoulder ... pad so you get maximum comfort while controlling your pain while using cold therapy. ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts ... Washington, D.C., for the 49th Congress of the International Society of Paediatric Oncology ... of the Center for Cancer and Blood Disorders at Children’s National, and ...
(Date:10/12/2017)... ... , ... Health Literacy Innovations (HLI), creator of the Health ... Cancer Patient Education Network (CPEN), an independent professional organization that shares best practices ... , As CPEN’s strategic partner, HLI will help support CPEN members by ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... Oct. 11, 2017  BioPharmX Corporation (NYSE MKT: BPMX) ... developed an innovative way to use nonlinear optical imaging ... of new drugs. ... Conference will show how researchers from BioPharmX and the ... School used a suite of imaging techniques in what ...
(Date:10/10/2017)...  NDS received FDA 510(k) clearance in May 2017 for its ... specifically designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... to support the improvement of patient outcomes, procedural efficiency, and the ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
Breaking Medicine Technology: